Seres Therapeutics
News/ News/ Sales and Marketing
Nestle gets closer to Seres, pledging $525m for microbiome C. diff drug
Phil Taylor
C. diff infections, infectious disease, microbiome, Nestlé Health Science, partnering, Seres Therapeutics
0 Comment
X
Nestle gets closer to Seres, pledging $525m for microbiome C. diff drug
https://pharmaphorum.com/news/nestle-gets-closer-to-seres-pledging-525m-for-microbiome-c-diff-drug/
AZ joins with Seres to research role of gut microbiome in cancer
Richard Staines
AstraZeneca, cancer, cancer immunotherapy, gastrointestinal, Seres Therapeutics
0 Comment
X
AZ joins with Seres to research role of gut microbiome in cancer
https://pharmaphorum.com/news/az-joins-with-seres-to-research-role-of-gut-microbiome-in-cancer/